Removal of medicaid restrictions were associated with increased hepatitis C virus treatment rates, but disparities persist

Despite the release of a growing number of direct‐acting antivirals and evolving policy landscape, many of those diagnosed with hepatitis C virus (HCV) have not received treatment. Those from vulnerable populations are at particular risk of being unable to access treatment, threatening World Health...

Descripción completa

Detalles Bibliográficos
Autores principales: Nephew, Lauren D., Wang, Yumin, Mohamed, Kawthar, Nichols, Deborah, Rawl, Susan M., Orman, Eric, Desai, Archita P., Patidar, Kavish R., Ghabril, Marwan, Chalasani, Naga, Kasting, Monica L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314034/
https://www.ncbi.nlm.nih.gov/pubmed/35254695
http://dx.doi.org/10.1111/jvh.13661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314034/
https://www.ncbi.nlm.nih.gov/pubmed/35254695
http://dx.doi.org/10.1111/jvh.13661

Ejemplares similares